148 related articles for article (PubMed ID: 24983371)
1. Key roles for MYC, KIT and RET signaling in secondary angiosarcomas.
Styring E; Seinen J; Dominguez-Valentin M; Domanski HA; Jönsson M; von Steyern FV; Hoekstra HJ; Suurmeijer AJ; Nilbert M
Br J Cancer; 2014 Jul; 111(2):407-12. PubMed ID: 24983371
[TBL] [Abstract][Full Text] [Related]
2. Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?
Laé M; Lebel A; Hamel-Viard F; Asselain B; Trassard M; Sastre X; Kirova YM
Cancer Radiother; 2015 May; 19(3):168-74. PubMed ID: 25863565
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.
Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ
Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083
[TBL] [Abstract][Full Text] [Related]
4. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.
Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD
J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953
[TBL] [Abstract][Full Text] [Related]
5. The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification.
Italiano A; Thomas R; Breen M; Zhang L; Crago AM; Singer S; Khanin R; Maki RG; Mihailovic A; Hafner M; Tuschl T; Antonescu CR
Genes Chromosomes Cancer; 2012 Jun; 51(6):569-78. PubMed ID: 22383169
[TBL] [Abstract][Full Text] [Related]
6. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit.
Miettinen M; Sarlomo-Rikala M; Lasota J
Mod Pathol; 2000 May; 13(5):536-41. PubMed ID: 10824925
[TBL] [Abstract][Full Text] [Related]
7. Influence of RET mutations on the expression of tyrosine kinases in medullary thyroid carcinoma.
Rodríguez-Antona C; Muñoz-Repeto I; Inglada-Pérez L; de Cubas AA; Mancikova V; Cañamero M; Maliszewska A; Gómez A; Letón R; Leandro-García LJ; Comino-Méndez I; Sanchez L; Alvarez-Escolá C; Aller J; Cascón A; Robledo M
Endocr Relat Cancer; 2013 Aug; 20(4):611-9. PubMed ID: 23780998
[TBL] [Abstract][Full Text] [Related]
8. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.
Manner J; Radlwimmer B; Hohenberger P; Mössinger K; Küffer S; Sauer C; Belharazem D; Zettl A; Coindre JM; Hallermann C; Hartmann JT; Katenkamp D; Katenkamp K; Schöffski P; Sciot R; Wozniak A; Lichter P; Marx A; Ströbel P
Am J Pathol; 2010 Jan; 176(1):34-9. PubMed ID: 20008140
[TBL] [Abstract][Full Text] [Related]
9. Array CGH analysis identifies two distinct subgroups of primary angiosarcoma of bone.
Verbeke SL; de Jong D; Bertoni F; Sciot R; Antonescu CR; Szuhai K; Bovée JV
Genes Chromosomes Cancer; 2015 Feb; 54(2):72-81. PubMed ID: 25231439
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic assessment of postradiation sarcomas: KIT as a potential treatment target.
Komdeur R; Hoekstra HJ; Molenaar WM; Van Den Berg E; Zwart N; Pras E; Plaza-Menacho I; Hofstra RM; Van Der Graaf WT
Clin Cancer Res; 2003 Aug; 9(8):2926-32. PubMed ID: 12912938
[TBL] [Abstract][Full Text] [Related]
11. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
[TBL] [Abstract][Full Text] [Related]
12. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
[TBL] [Abstract][Full Text] [Related]
13. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
[TBL] [Abstract][Full Text] [Related]
14. Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract][Full Text] [Related]
15. The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast.
Kuba MG; Xu B; D'Angelo SP; Rosenbaum E; Plitas G; Ross DS; Brogi E; Antonescu CR
Histopathology; 2021 Nov; 79(5):836-846. PubMed ID: 34165212
[TBL] [Abstract][Full Text] [Related]
16. MYC amplification in angiosarcomas arising in the setting of chronic lymphedema of morbid obesity.
Harker D; Jennings M; McDonough P; Mauskar M; Savory S; Hosler GA; Vandergriff T
J Cutan Pathol; 2017 Jan; 44(1):15-19. PubMed ID: 27686553
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study.
Requena C; Rubio L; Lavernia J; Machado I; Llombart B; Sanmartín O; Traves V; Guillén C; Cruz J
Am J Dermatopathol; 2018 May; 40(5):349-354. PubMed ID: 29135507
[TBL] [Abstract][Full Text] [Related]
18. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.
Fanburg-Smith JC; Furlong MA; Childers EL
Mod Pathol; 2003 Mar; 16(3):263-71. PubMed ID: 12640107
[TBL] [Abstract][Full Text] [Related]
19. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.
Guo T; Zhang L; Chang NE; Singer S; Maki RG; Antonescu CR
Genes Chromosomes Cancer; 2011 Jan; 50(1):25-33. PubMed ID: 20949568
[TBL] [Abstract][Full Text] [Related]
20. Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma.
Grubbs EG; Williams MD; Scheet P; Vattathil S; Perrier ND; Lee JE; Gagel RF; Hai T; Feng L; Cabanillas ME; Cote GJ
Thyroid; 2016 Nov; 26(11):1553-1562. PubMed ID: 27610696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]